Aptose Biosciences (APTO) News Today $0.57 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 3:12 AM | americanbankingnews.comAptose Biosciences Inc. (NASDAQ:APTO) Receives Average Recommendation of "Buy" from BrokeragesJuly 24 at 4:34 AM | americanbankingnews.comStockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)July 19, 2024 | globenewswire.comAptose Announces Receipt of Deficiency Notice from NasdaqJuly 17, 2024 | americanbankingnews.comAptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.comJune 18, 2024 | globenewswire.comAptose Announces Results from Annual and Special Meeting of ShareholdersJune 14, 2024 | globenewswire.comAptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid CongressJune 3, 2024 | globenewswire.comAptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 31, 2024 | globenewswire.comAptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 14, 2024 | globenewswire.comAptose Reports Results for the First Quarter 2024May 6, 2024 | globenewswire.comAptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024March 29, 2024 | investing.comAptose Biosciences target cut, maintains buy rating on new drug developmentMarch 28, 2024 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Reports Results for the Fourth Quarter and Full Year 2023March 27, 2024 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | msn.comEdgewood secures $20m in Series A for clinical development of cancer therapyMarch 27, 2024 | benzinga.comRecap: Aptose Biosciences Q4 EarningsMarch 26, 2024 | globenewswire.comAptose Reports Results for the Fourth Quarter and Full Year 2023March 18, 2024 | globenewswire.comAptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024January 29, 2024 | finance.yahoo.comThis Aptose Biosciences Insider Increased Their Holding In The Last YearJanuary 26, 2024 | marketwatch.comAptose Biosciences Shares Drop 11% After Private, Public OfferingsJanuary 26, 2024 | markets.businessinsider.comAptose Prices Offering Of About 4.91 Mln Shares At $1.71/Share, $4 Private Placement With HanmiJanuary 26, 2024 | finance.yahoo.comAptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi PharmaceuticalJanuary 26, 2024 | investorplace.comWhy Is Aptose Biosciences (APTO) Stock Down Today?December 21, 2023 | benzinga.comAptose Biosciences Stock (NASDAQ:APTO), Guidance and ForecastDecember 5, 2023 | morningstar.comAptose Biosciences Inc APTODecember 4, 2023 | msn.comAptose Biosciences files to sell ordinary shares, warrantsDecember 1, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive RoleNovember 12, 2023 | seekingalpha.comAptose Biosciences Inc. (APTO) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | benzinga.comAptose Biosciences Stock (NASDAQ:APTO) Earnings Dates and Earning CallsNovember 10, 2023 | benzinga.comAptose Biosciences: Q3 Earnings InsightsNovember 10, 2023 | markets.businessinsider.comPromising Financial Performance and Clinical Developments Bolster Aptose Biosciences’ Buy Rating: An Analysis by Joseph PantginisNovember 9, 2023 | msn.comAptose Biosciences GAAP EPS of -$1.76 beats by $0.22November 1, 2023 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Aptose Biosciences (APTO)November 1, 2023 | markets.businessinsider.comPromising Trial Data and Expansion Plans Boost Confidence in Aptose Biosciences: An Analysis of John Newman’s Buy RatingOctober 30, 2023 | finance.yahoo.comAptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug TuspetinibOctober 16, 2023 | finance.yahoo.comAptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International ConferenceOctober 12, 2023 | theglobeandmail.comAptose Biosciences: Bottom 25 Performing Stocks Year-to-Date on TSX (APS)September 8, 2023 | finance.yahoo.comCompanies Like Aptose Biosciences (TSE:APS) Could Be Quite RiskySeptember 7, 2023 | finance.yahoo.comHANMI FILES EARLY WARNING REPORT IN RESPECT OF APTOSE BIOSCIENCES INC.September 7, 2023 | markets.businessinsider.comExpert Ratings for Aptose BiosciencesAugust 29, 2023 | marketbeat.comShort Interest in Aptose Biosciences Inc. (NASDAQ:APTO) Declines By 12.8%Aptose Biosciences Inc. (NASDAQ:APTO - Get Free Report) (TSE:APS) saw a large decline in short interest in August. As of August 15th, there was short interest totalling 40,700 shares, a decline of 12.8% from the July 31st total of 46,700 shares. Based on an average daily trading volume, of 47,600 shares, the days-to-cover ratio is presently 0.9 days. Approximately 1.3% of the shares of the stock are sold short.August 24, 2023 | finance.yahoo.comAptose to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 23, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc down on Tuesday (APS)August 18, 2023 | fool.comAptose Biosciences (NASDAQ: APTO)August 11, 2023 | markets.businessinsider.comRBC Capital Maintains Outperform Rating for Aptose Biosciences: Here's What You Need To KnowAugust 11, 2023 | marketbeat.comRoyal Bank of Canada Cuts Aptose Biosciences (NASDAQ:APTO) Price Target to $23.00Royal Bank of Canada decreased their price target on shares of Aptose Biosciences from $40.00 to $23.00 in a report on Friday.August 11, 2023 | marketbeat.comAptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Rating of "Buy" from AnalystsShares of Aptose Biosciences Inc. (NASDAQ:APTO - Get Free Report) (TSE:APS) have earned an average recommendation of "Buy" from the five analysts that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12 month price targAugust 11, 2023 | msn.comAptose Biosciences GAAP EPS of -$2.27 misses by $0.34August 2, 2023 | msn.comAptose Biosciences (APTO) Price Target Increased by 1614.75% to 62.90July 28, 2023 | finance.yahoo.comAptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023June 27, 2023 | finance.yahoo.comAPTO - Aptose Biosciences Inc. Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter. Email Address This student turned $1,300 into $45,000 in just 4 Months! (Ad)With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY. See here to see the full details. APTO Media Mentions By Week APTO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APTO News Sentiment▼0.580.61▲Average Medical News Sentiment APTO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APTO Articles This Week▼40▲APTO Articles Average Week Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Protara Therapeutics News Today Dyadic International News Today Aligos Therapeutics News Today Curis News Today IN8bio News Today Cyclo Therapeutics News Today Achilles Therapeutics News Today Quince Therapeutics News Today NKGen Biotech News Today MiNK Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APTO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.